OphthalmologyClinical
Diabetic Macular EdemaAVD-104
Aviceda’s high affinity ligand engages Siglecs to decrease neutrophil and macrophage activation and reduce inflammatory mediators to reduce diabetic macular edema.
Aviceda’s high affinity ligand engages Siglecs to decrease neutrophil and macrophage activation and reduce inflammatory mediators to reduce diabetic macular edema.